JACOBS LEVY EQUITY MANAGEMENT, INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,172,498
-21.7%
965,856
+19.4%
0.02%
-19.4%
Q2 2023$5,331,046
-12.4%
808,960
-9.8%
0.03%
-16.2%
Q1 2023$6,087,283
-3.1%
896,507
+5.4%
0.04%
-14.0%
Q4 2022$6,284,050
-25.7%
850,345
-0.7%
0.04%
-35.8%
Q3 2022$8,457,000
-24.8%
855,970
-17.0%
0.07%
-23.0%
Q2 2022$11,243,000
+1131.4%
1,031,495
+1178.5%
0.09%
+1350.0%
Q1 2022$913,000
-39.1%
80,683
-7.8%
0.01%
-40.0%
Q3 2021$1,500,000
-68.5%
87,493
-60.5%
0.01%
-68.8%
Q2 2021$4,767,000
-55.2%
221,634
-68.7%
0.03%
-61.0%
Q1 2021$10,641,000
+7.8%
708,488
-5.7%
0.08%
-5.7%
Q4 2020$9,874,000
+128.1%
751,439
+67.7%
0.09%
+93.3%
Q3 2020$4,329,000
+1726.6%
448,144
+3374.0%
0.04%
+1400.0%
Q1 2019$237,000
-90.7%
12,900
-86.8%
0.00%
-93.3%
Q4 2018$2,549,000
+211.6%
97,535
+173.8%
0.04%
+275.0%
Q3 2018$818,000
+3.9%
35,625
-13.7%
0.01%0.0%
Q2 2018$787,000
+33.8%
41,300
+18.4%
0.01%
+20.0%
Q1 2018$588,000
+71.9%
34,890
+55.1%
0.01%
+66.7%
Q4 2017$342,00022,4900.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders